Fundus autofluorescence (FAF) is a non-invasive imaging technique that enables the visualization of lipofuscin changes in the retinal pigment epithelium. This study aims to illustrate the spectrum of FAF changes in a variety of retinal dystrophies. For this purpose, we examined patients with retinal dystrophies such as Stargardt disease, Best vitelliform macular dystrophy, and retinal dystrophies associated with mutations in the peripherin/RDS gene. All retinal dystrophies were confirmed by molecular genetic analysis. A broad range of characteristic FAF patterns was observed. Our results indicate that FAF imaging constitutes a useful additive tool in the diagnosis and follow-up of various retinal dystrophies.
Introduction
During the last decade, fundus autofluorescence (FAF) imaging of the retina has emerged as a useful, non-invasive imaging technique in the diagnosis and follow-up of several retinal dystrophies (Robson et al., 2006; von Rü ckmann, Fitzke, & Bird, 1997 Wabbels, Preising, Kretschmann, Demmler, & Lorenz, 2006b; Wabbels et al., 2006a) . Obtaining sufficient-quality FAF images generally becomes feasible starting from 5 years of age (Wabbels et al., 2006a ). Short-wavelength excited FAF origins from fluorophores within the retinal pigment epithelium (RPE), and RPE lipofuscin distribution is the principal cause for the observed FAF patterns (Delori et al., 1995a) . Lipofuscin contains a mixture of fluorescent molecules that are by-products of the visual cycle, many of which have not been thoroughly characterized to date (Bui, Han, Radu, Travis, & Mata, 2006; Delori et al., 1995b; Eldred & Katz, 1988; Sparrow & Boulton, 2005) .
The major lipofuscin fluorophore is A2E, which exerts diverse toxic effects on the RPE (Lakkaraju, Finnemann, & Rodriguez-Boulan, 2007; Sparrow & Boulton, 2005; Sparrow & Cai, 2001; Sparrow, Cai, Jang, Zhou, & Nakanishi, 2006; Sparrow, Nakanishi, & Parish, 2000; Sparrow et al., 2003b Sparrow et al., , 2003c Weiter, Delori, Wing, & Fitch, 1986; Zhou, Jang, Kim, & Sparrow, 2006) . While the slight and diffuse increase of lipofuscin with ageing is physiologic, extensive and focal accumulation of lipofuscin is pathologic and may be encountered in a variety of retinal dystrophies (Delori, Goger, & Dorey, 2001; Sparrow et al., 2003a,b; Weiter et al., 1986) . Histopathological studies have found an excessive accumulation of lipofuscin and/ or A2E in several retinal dystrophies, including those associated with mutations in the ABCA4 gene, the VMD2 (BEST1) gene, and the peripherin/RDS gene (Bakall et al., 2007; Mata, Weng, & Travis, 2000; Zhang, Garibaldi, Li, Green, & Zack, 2002) . The present study illustrates the appearance of characteristic FAF patterns in selected, relatively frequent retinal dystrophies. 
Materials and methods

Autofluorescence imaging
FAF imaging was performed with a confocal scanning laser ophthalmoscope (cSLO, Heidelberg Retina Angiograph 2; Heidelberg Engineering, Dossenheim, Germany) and all images were acquired by the same operator (CJFB). After pupil dilation to at least 6 mm with one drop of phenylephrine and one drop of tropicamide, FAF imaging was performed using the 30°field of view and a resolution of 1536 Â 1536 pixels, using an optically pumped solid state laser (488 nm) for excitation. A barrier filter at 500 nm suppressed the blue argon excitation light, so that reflectance signals did not contribute to the FAF image obtained from the posterior pole of the examined eye.
For the acquisition of FAF images, a standard procedure was followed, which included focusing of the retinal image in the infrared reflection mode at 820 nm, sensitivity adjustment at 488 nm and acquisition of 9 single 30°Â 30°FAF images which encompassed the entire macular area and at least part of the optic disc. In order to improve the signal-to-noise ratio of the FAF signal, the nine single images were aligned and a mean image was calculated after detection and correction of eye movements using the software provided by the manufacturer (Heidelberg Eye Explorer, Heidelberg Engineering, Dossenheim, Germany). Images were digitized and saved on hard disc for further analysis and processing. In general, areas of increased FAF are believed to represent lipofuscin increase either within or outside RPE cells, whereas decreased FAF may indicate RPE cell death and atrophy of the RPE-photoreceptor complex.
Patients
A total of 112 patients with a variety of retinal dystrophies participated in the study. All examinations were undertaken with the understanding and written consent of each subject, and all procedures were conducted in accordance with the Declaration of Helsinki. All patients were consecutively seen in a tertiary referral setting at the Department of Ophthalmology of the Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
We included 8 patients with autosomal recessive Stargardt diseasefundus flavimaculatus (STGD1), 27 patients with Best vitelliform macular dystrophy (BVMD), 48 patients with central areolar choroidal dystrophy (CACD), and 29 patients with some form of pattern dystrophy: 9 of these patients had the adult-onset foveomacular vitelliform dystrophy (AFVD) subtype, 16 patients were diagnosed with multifocal pattern dystrophy simulating STGD1, one patient had butterfly-shaped pattern dystrophy and 3 patients had pattern dystrophy related to ''maternally inherited diabetes and deafness" (MIDD).
In all STGD1 patients, the diagnosis was confirmed by the identification of 2 compound heterozygous mutations in the ABCA4 gene. In all 27 BVMD patients, the diagnosis was confirmed by an absent light rise on the electro-oculogram and the finding of a specific variant in the VMD2 gene. All patients with CACD and multifocal pattern dystrophy simulating STGD1, as well as the patient with butterfly-shaped pattern dystrophy, carried mutations in the peripherin/RDS gene. The study population of patients with multifocal pattern dystrophy simulating STGD1 was a subset of recently reported patients (Boon et al., 2007a) . In the AFVD patients, no mutations in VMD2 or peripherin/RDS were identified. This is in accordance with a recent study that found that mutations in these genes are relatively rare in AFVD patients (Zhuk & Edwards, 2006) . The patients with MIDD-related pattern dystrophy carried a mitochondrial 3243A>G mutation.
After their medical history was obtained, all patients underwent an extensive ophthalmic examination, including best-corrected Snellen visual acuity, indirect ophthalmoscopy and fundus photography. In addition to FAF imaging, subsequent examination included optical coherence tomography and, in selected cases, fluorescein angiography, electroretinography and electro-oculography.
Results
Autosomal recessive Stargardt disease-fundus flavimaculatus (STGD1)
In our study group, all STGD1 patients displayed FAF abnormalities. Six STGD1 patients showed areas of focally increased FAF, sometimes bordered by a zone of decreased FAF. In addition, spots of decreased FAF were visible in these patients. In two patients, these areas of altered FAF were restricted to the macula (Fig. 1A) , while four patients showed a distribution of these flecks throughout or beyond the posterior pole. Many of these flecks corresponded with irregular yellowish flecks at ophthalmoscopy, but some flecks of increased FAF were not seen at ophthalmoscopy. The highest number of these extramacular flecks was seen in the nasal retina (Fig. 1B) . Two patients showed a diffusely increased FAF pattern throughout the fundus, with a speckled pattern of small areas of decreased FAF. In these patients, a large area of markedly decreased FAF could be observed in the macula (Fig. 1C ). Seven patients showed relatively normal FAF in the parapapillary zone, but one patient showed parapapillary FAF abnormalities (Fig. 1C) .
Best vitelliform macular dystrophy
All patients with Best vitelliform macular dystrophy in our study group displayed FAF abnormalities, except both patients who were in the carrier stage, in whom FAF abnormalities were either very discrete or absent ( Fig. 2A) . At lesions in earlier stages, in which vitelliform material appeared more abundant at ophthalmoscopy, FAF imaging displayed areas of markedly increased FAF. In the vitelliform stage, the round lesions showed homogeneously increased FAF (Fig. 2B ). In the pseudohypopyon stage, FAF was visible mainly in the inferior portion of the lesion, co-locating with the ophthalmoscopically visible pseudohypopyon (Fig. 2C ). In the vitelliruptive or scrambled-egg stage, the amount of autofluorescent material was reduced to a certain extent and condensed mainly at the borders of the lesion, whereas the central part of the lesion showed slightly decreased FAF (Fig. 2D ). In the atrophic stage, areas corresponding with chorioretinal atrophy corresponded with a major decrease of the FAF signal (Fig. 2E ). Reduced FAF also dominated in the cicatricial stage. However, some spots of discretely increased FAF were present within these areas of decreased FAF (Fig. 2F ). In general, FAF imaging was able to visualize even very small amounts of vitelliform material that were not readily seen at ophthalmoscopy.
Finally, one patient displayed a spoke-like pattern of FAF changes simulating macular pattern dystrophy (Fig. 2G ), while another patient had multifocal vitelliform lesions (Fig. 2H ).
Central areolar choroidal dystrophy
In central areolar choroidal dystrophy (CACD), we will describe FAF characteristics in the stages of CACD as described by . In stage I CACD, a discrete speckled increase of FAF was observed in the parafoveal area (Fig. 3A) . The FAF abnormalities corresponding with early stage II involved a speckled, round to oval area of predominantly increased FAF. This area of abnormal FAF enlarged towards late stage II, and the spots of increased FAF within the lesion decreased in favour of speckles of decreased FAF. Stage III was characterized by the appearance of extrafoveal, well-defined areas of absent FAF, which corresponded with chorioretinal atrophy at ophthalmoscopy (Fig. 3B ). These areas enlarged and multiplied on follow-up ( was characterized by foveal involvement of the area of absent FAF. Eventually, a round to oval area of virtually absent FAF was seen in patients with end-stage CACD, bordered by a small band of increased FAF (Fig. 3D) .
Pattern dystrophies 3.4.1. Adult-onset foveomacular vitelliform dystrophy
The vitelliform lesions in the patients with AFVD corresponded with round to oval lesions with increased FAF in 8 patients (Fig. 4A ), sometimes with a small spot of reduced FAF. Two patients had unilateral disease. In two patients, zones of increased and decreased AF were seen within the same lesion. One of these patients had lesions displaying characteristics of scrambled-egg and pseudohypopyon. In another patient, the lesion in one eye showed decreased FAF, corresponding with chorioretinal atrophy at ophthalmoscopy. Small multifocal lesions of increased FAF were seen in the macular area of one patient. In all patients, lesions were smaller than one disc diameter on FAF.
Multifocal pattern dystrophy simulating STGD1
In general, FAF in patients with multifocal pattern dystrophy simulating STGD1 shows changes that are very similar to the FAF changes seen in patients with the fundus flavimaculatus subtype of STGD1. In multifocal pattern dystrophy simulating STGD1, the STGD1-like flecks displayed highly increased FAF, often with small adjacent zones of decreased FAF (Fig. 4B) . In a later stage, these flecks of increased FAF showed confluence towards a large ring-shaped area of mottled FAF abnormalities surrounding the macula and optic disc, without sparing of the parapapillary retina (Fig. 4C) . The changes could gradually involve the macula (Fig. 4C) . Within this ring-shaped area of increased FAF, granular zones of substantially decreased FAF appeared. After one or more decades of disease, profound chorioretinal atrophy of the posterior pole could occur, which corresponded with a severely decreased or absent FAF signal. In the macular area, FAF changes were variable. In 8 eyes, discrete spots of either increased or decreased FAF were seen in the fovea. A group of irregular central flecks of mostly increased FAF, similar in shape, but generally larger than the peripheral flecks, was seen in 7 eyes. In 8 eyes of 5 patients, large, irregularly shaped lesions were seen, showing spots of increased and decreased FAF. In one eye, a butterflyshaped lesion was seen on FAF as well as at ophthalmoscopy. One or more well-defined areas of severely decreased FAF could be observed in 8 eyes of 5 patients, corresponding with profound chorioretinal atrophy (Fig. 4C) .
Butterfly-shaped pigment dystrophy
We examined one patient with butterfly-shaped pigment dystrophy, in whom the butterfly-shaped lesions at ophthalmoscopy were also observed on FAF (Fig. 4D) . The pigmented part of the butterfly-shaped lesion showed increased FAF, and was surrounded by decreased FAF.
Pattern dystrophy associated with maternally inherited diabetes and deafness (MIDD)
In one MIDD patient, spots of decreased and increased FAF were scattered throughout the macula, in one eye with a central area of increased FAF corresponding with a pseudovitelliform lesion at ophthalmoscopy (Fig. 4E) . Another patient displayed the same speckled aspect of spots of increased and decreased FAF, with a relatively normal FAF aspect of the fovea (Fig. 4F) . The third MIDD patient who displayed advanced FAF changes in the posterior pole and around the optic nerve, showed apparently normal FAF of both foveas, corresponding with a normal visual acuity (Fig. 4G ).
Discussion
In the present study, FAF abnormalities were observed in all examined eyes with ophthalmoscopically visible retinal dystrophies. Focally increased FAF was the most common finding, frequently accompanied by areas of decreased or even absent FAF. We observed specific FAF abnormalities that were dependent on the examined retinal disorder. 
FAF in STGD1
Autosomal recessive Stargardt disease/fundus flavimaculatus (STGD1) is caused by mutations in the ABCA4 gene (Allikmets et al., 1997) . With disease progression, excessive increase of lipofuscin and especially A2E can be observed, which is accelerated by light exposure (Cideciyan et al., 2004; Delori et al., 1995a,b; Weng et al., 1999) . This abnormal increase of RPE lipofuscin is probably the first detectable pathophysiological change in STGD1 (Cideciyan et al., 2004) . Therefore, FAF imaging appears a promising method to monitor patients with STGD1 (Lois, Halfyard, Bird, Holder, & Fitzke, 2004) .
In our study, central macular lesions showed largely decreased FAF, reflecting chorioretinal atrophy. In most patients, these central lesions were surrounded by smaller, well-circumscribed lesions of predominantly increased FAF, largely corresponding with the irregularly shaped yellowish flecks that were observed at ophthalmoscopy. However, some of these lesions on FAF were not readily seen at ophthalmoscopy. This emphasizes the potential of FAF to detect pathologic changes in STGD1 in advance to clinically visible abnormalities. Lesions were sometimes confined to the macula, but an innumerable amount of flecks of increased FAF, scattered throughout the retina, could also be observed. Like in the normal retina (Delori et al., 2001) , the rate of lipofuscin accumulation in STGD1 shows considerable intraretinal variation (Cideciyan et al., 2004 (Cideciyan et al., , 2005a . A disease sequence of six stages has been proposed by Cideciyan et al. (2004) , based on lipofuscin accumulation, retinoid cycle kinetics, as well as rod, cone and RPE cell loss. Stage I shows entirely normal results, while the only detectable abnormality in stage II is an increase in mean FAF intensity. In stage III, these changes are superimposed by a focal increase of FAF intensity (Fig. 1A and  B) . Different FAF patterns have been described in STGD1, which appear to correspond with functional abnormalities (Gerth et al., 2002; Lois et al., 2004) . Lesions tend to enlarge and show confluence, while the initially elevated FAF signal evolves towards decreased to absent FAF intensities. These decreasing FAF intensities are due to the loss of lipofuscinladen RPE cells, accompanied by increasing photoreceptor degeneration and slowing of the retinoid cycle. In stage VI (end-stage) ABCA4-related retinal degeneration, variably sized regions of absent FAF are observed as a consequence of complete RPE and photoreceptor degeneration.
In cases of STGD1 with abnormal cone and rod responses on electroretinography, most patients show a decreased FAF signal at the macula, sometimes in combination with patches of decreased FAF beyond the vascular arcades, corresponding with chorioretinal atrophy. This group of STGD1 patients also tends to show more visual loss (Lois et al., 2004) . Although there is no direct evidence that conventional short-wavelength FAF accelerates the disease process of ABCA4-related retinal dystrophies, there are indications that some retinal degenerative diseases like STGD1 may have lower light damage thresholds (Cideciyan et al., 2005a (Cideciyan et al., ,b, 2007 Mata et al., 2000; Paskowitz, Lavail, & Duncan, 2006) . Therefore, some authors advocate the use of reduced intensity FAF imaging (Cideciyan et al., 2007; Paskowitz et al., 2006) .
FAF in Best vitelliform macular dystrophy
BVMD is an autosomal dominant retinal dystrophy that predominantly affects the macula. BVMD is caused by mutations in the VMD2 gene (Petrukhin et al., 1998) . Typically, BVMD patients show bilateral round to oval yellow subretinal lesions in the macula that resemble an egg-yolk at a certain point of time (Gass, 1997) . In a minority of cases, multifocal vitelliform lesions may be encountered (Boon et al., 2007b; Mullins, Oh, Heffron, Hageman, & Stone, 2005) . Most histopathological studies have found an abnormal increase of RPE lipofuscin and A2E in the RPE of donor eyes of BVMD patients (Bakall et Flaherty, Fishman, & Berson, 1988; Weingeist, Kobrin, & Watzke, 1982) .
In our study, FAF imaging allowed a detailed appreciation of the lesions in all BVMD patients. FAF was also able to visualize small amounts of vitelliform material that were not seen at ophthalmoscopy. In early stages, BVMD lesions showed a predominantly increased FAF, which decreased towards later stages. Previous studies indicate that lesions may remain relatively constant in size (Wabbels, Preising, Kretschmann, Demmler, & Lorenz, 2006b ), but they may also enlarge when evolving to later stages (Renner et al., 2005; Spaide, Noble, Morgan, & Freund, 2006) . In virtually all patients, internal FAF characteristics change substantially during follow-up (Wabbels et al., 2006b) . Lower visual acuity appears to be associated with a more irregular pattern of increased FAF within the lesion, due to scarring or hemorrhage (Jarc-Vidmar, Kraut, & Hawlina, 2003; Wabbels et al., 2006b ). In our study, lesions in later stages of BVMD were characterized by a generally decreased FAF. This gradual loss of FAF in later disease stages indicates that this subretinal material of increased FAF gradually disappears when RPE cell death progresses and atrophy or scars develop.
FAF in central areolar choroidal dystrophy
Most cases of autosomal dominant CACD appear to be associated with mutations in the peripherin/RDS gene, but genetic heterogeneity has been described (Downes et al., 1999; Hughes, Lotery, & Silvestri, 1998) . In our study, patients with autosomal dominant CACD showed increased FAF in the macular area early in the course of the disease, suggesting lipofuscin accumulation in the macular RPE. In late stage II CACD, zones of decreased FAF may become more prominent, suggesting gradual loss of RPE cells. Thus, our FAF findings indicate a progressive lipofuscin accumulation and consecutive RPE damage during the first two stages. With time, lesions may extend beyond the retinal vascular arcades and optic nerve head (Downes et al., 1999; Keilhauer, Meigen, & Weber, 2006) . FAF in stage III CACD shows sharply demarcated areas of severely decreased to absent FAF. These atrophic areas develop within areas of speckled FAF changes. Therefore, these initial diffusely RPE affections may result in regions of total loss of RPE, which enlarge and finally involve the foveal RPE in end-stage CACD. In this stage, a well-defined, round to oval area of absent FAF is seen, bordered by a small area of increased FAF. Interestingly, FAF abnormalities may precede ophthalmoscopically visible changes in CACD (Downes et al., 1999) . This makes FAF imaging especially suitable for non-invasive screening of families with CACD.
FAF in pattern dystrophies
The phenotypically and genetically heterogeneous group of pattern dystrophies is characterized by a variety of deposits of yellow, orange or gray pigment, predominantly in the macular area (Francis et al., 2005; Marmor & Byers, 1977; Pinckers, 1988; Weigell-Weber, Kryenbuhl, Buchi, & Spiegel, 1996) . The classification of Gass discriminates between five main categories of pattern dystrophies: adult-onset foveomacular vitelliform dystrophy (AFVD), butterfly-shaped pigment dystrophy, reticular dystrophy of the pigment epithelium, multifocal pattern dystrophy simulating fundus flavimaculatus (MPD), and fundus pulverulentus (Gass, 1997) . In the group of AFVD patients in the present study, all lesions were smaller than one disc diameter in size and generally showed increased FAF. These results correspond with previous FAF findings in AFVD patients and with the histopathologic finding of increased lipofuscin in AFVD lesions (Dubovy et al., 2000; Patrinely, Lewis, & Font, 1985; Renner et al., 2004) . One patient showed small multifocal lesions of increased FAF, while another patient had lesions with a scrambled-egg and pseudohypopyon aspect, features that are also seen in BVMD.
In patients with MPD, which is often caused by peripherin/RDS mutations, the posterior pole may be scattered with irregular flecks mimicking STGD1 on FAF, as well as on ophthalmoscopy and optical coherence tomography (Boon et al., 2007a) . Like in STGD1, the flecks in MPD may extend beyond the macular area. In later stages, these flecks may show confluence to a ring-shaped area of abnormal FAF, surrounding the macula and optic disc. Central macular lesions show a broad range of FAF changes, often with predominantly increased FAF, especially in earlier stages. In time, macular lesions may also show markedly decreased FAF due to profound chorioretinal atrophy. Therefore, it may be difficult to discriminate between STGD1 and MPD on the basis of the FAF aspect. Distinguishing features between MPD and STGD1 are the autosomal dominant pattern of inheritance, the relatively late age at onset, the comparatively good and stable visual acuity and the absence of a ''dark choroid" on fluorescein angiography (Boon et al., 2007a) . Molecular genetic analysis may aid in the differential diagnosis between these different entities.
In butterfly-shaped pigment dystrophy, patients display macular lesions with a spoke-like pigment pattern surrounded by a zone of depigmentation, thus somewhat resembling the shape of a butterfly (Deutman, van Blommestein, Henkes, Waardenburg, & Solleveld-van Driest, 1970) . The phenotype of butterfly-shaped pigment dystrophy is genetically heterogeneous (van Lith-Verhoeven, Cremers, van den Helm, Hoyng, & Deutman, 2003; Zhang et al., 2002) . In a case caused by a peripherin/RDS missense mutation (Cys213Tyr), increased amounts of lipofuscin have been found in the RPE on histopathologic examination (Zhang et al., 2002) . This corresponds with the finding in our study of increased FAF of the pigmented part of the lesion in the patient with butterfly-shaped pigment dystrophy.
Pattern dystrophy phenotypes may also be associated with syndromes, such as myotonic dystrophy, pigment dispersion syndrome, and mitochondrial syndromes like maternally inherited diabetes and deafness (MIDD) and MELAS (mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes) syndrome (Chew & Deutman, 1983; Chew, Deutman, & Cruysberg, 1985; Hayasaka et al., 1984; Isashiki et al., 1998; Massin et al., 1999) . MIDD and MELAS are associated with mutations in the mitochondrial DNA, the 3243A>G point mutation being the most frequently identified mutation (Malecki, 2005) . As much as 86% of patients with maternally inherited diabetes and deafness (MIDD) may show some form of pattern dystrophy. In our study, RPE changes in MIDD patients were easily defined on FAF as speckled areas of increased and decreased FAF in the macula and surrounding the optic disc. The intriguing feature of foveal sparing (Bellmann et al., 2004) can be observed on FAF in a MIDD patient with advanced pattern dystrophy, which is illustrated in Fig. 4G .
Conclusions
FAF imaging is a useful tool for the identification and follow-up of lesions associated with lipofuscin accumulation or RPE cell loss. As such, FAF imaging may yield important additional information in a diagnostic setting in relatively frequent retinal dystrophies such as STGD1, BVMD and in retinal dystrophies associated with peripherin/RDS mutations. FAF may visualize more lesions compared to ophthalmoscopy. Moreover, FAF imaging provides qualitative information, as it reflects the lipofuscin content in lesions, and FAF changes appear to relate to functional abnormalities in at least some retinal dystrophies (Lois et al., 2004; Robson et al., 2003 Robson et al., , 2006 . However, non-lipofuscin accumulating parts of a lesion may be missed with FAF. Therefore, FAF alone may not be useful for lesion size measurement.
Retinal dystrophies may present with a considerable clinical variability. Late stages with RPE cell loss may look similar in various retinal dystrophies and in other retinal disorders such as age-related macular degeneration. In this respect, FAF may be of limited use in the differential diagnosis between different forms of retinal dystrophy. Molecular genetic testing may be very helpful in these cases. Compared to fluorescein angiography, FAF imaging, as a non-invasive imaging modality, is a straightforward and relatively patient-friendly means to get an overview of the accumulation of fluorophores like lipofuscin and atrophic changes within the RPE-photoreceptor complex (Delori et al., 1995a,b; von Rü ckmann et al., 1997) . Therefore, FAF imaging may constitute a convenient tool for cross-sectional and family studies, as well as in the follow-up of various retinal dystrophies. In addition, FAF imaging may also play a role as a parameter for the evaluation of therapeutic effects in future clinical treatment trials.
